Literature DB >> 12394997

Performance-based gait tests for acute stroke patients.

Inácio Teixeira Cunha1, Peter A C Lim, Helene Henson, Trilok Monga, Huma Qureshy, Elizabeth J Protas.   

Abstract

OBJECTIVE: Qualitative measures may not differentiate severity of deficits after an acute or subacute stroke. The aim of this study was to contrast the utility of performance-based gait tests with qualitative measures in a sample of acute stroke patients.
DESIGN: Twenty acute stroke subjects had their performance-based gait measured by gait speed, walking distance, gait energy expenditure, and gait energy cost. They were also qualitatively evaluated for cognition, functional outcomes, motor impairment, and Functional Ambulation Category.
RESULTS: Strong and significant correlations were observed among performance-based gait tests. Qualitative scales indicated moderate to minimal deficits in each domain evaluated, although they were not correlated among themselves, except for Functional Ambulation Category and FIM and FIM and Mini-Mental State Exam. Functional Ambulation Category correlated with performance-based gait tests.
CONCLUSIONS: Performance-based gait tests are feasible to conduct during early recovery after a stroke and allow better discrimination among the patients than qualitative measures.

Entities:  

Mesh:

Year:  2002        PMID: 12394997     DOI: 10.1097/00002060-200211000-00008

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  30 in total

1.  Energy expenditure during gait in patients with mucopolysaccharidosis.

Authors:  Marcos Almeida Matos; André Prado; Gustavo Schenkel; Rosa Barreto; Angelina Xavier Acosta
Journal:  Acta Ortop Bras       Date:  2013-03       Impact factor: 0.513

2.  The fate of injured corticospinal tracts in patients with intracerebral hemorrhage: diffusion tensor imaging study.

Authors:  Y J Jung; S H Jang
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-05       Impact factor: 3.825

3.  Incidence and characteristics of physical disabilities in patients with postconcussion syndromefollowing mTBI.

Authors:  Sung Ho Jang; Eun Bi Choi; Young Seo Lee
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

4.  Effect of Surgery on Gait and Sensory Motor Performance in Patients With Cervical Spondylotic Myelopathy.

Authors:  Kingsley O Abode-Iyamah; Stephanus V Viljoen; Colleen L McHenry; Michael A Petrie; Kirsten E Stoner; Nader S Dahdaleh; Nicole M Grosland; Matthew A Howard; Richard K Shields
Journal:  Neurosurgery       Date:  2016-11       Impact factor: 4.654

5.  Injury of corticoreticular pathway and corticospinal tract caused by ventriculoperitoneal shunting.

Authors:  Sung Ho Jang; Jeong Pyo Seo
Journal:  Neural Regen Res       Date:  2015-11       Impact factor: 5.135

6.  Gait deterioration due to neural degeneration of the corticoreticular pathway: a case report.

Authors:  Sung Ho Jang; Han Do Lee
Journal:  Neural Regen Res       Date:  2016-04       Impact factor: 5.135

7.  Central post-stroke pain due to injury of the medial lemniscus in a patient with medullary infarction.

Authors:  Sung Ho Jang; Hyeok Gyu Kwon
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

8.  Outcomes of drug-resistant urinary retention in patients in the early stage of stroke.

Authors:  Tae Gyun Kim; Min Ho Chun; Min Cheol Chang; Seoyon Yang
Journal:  Ann Rehabil Med       Date:  2015-04-24

9.  Dual-channel functional electrical stimulation improvements in speed-based gait classifications.

Authors:  Shmuel Springer; Yocheved Laufer; Meni Becher; Jean-Jacques Vatine
Journal:  Clin Interv Aging       Date:  2013-02-28       Impact factor: 4.458

10.  Walking performance: correlation between energy cost of walking and walking participation. new statistical approach concerning outcome measurement.

Authors:  Marco Franceschini; Anais Rampello; Maurizio Agosti; Maurizio Massucci; Federica Bovolenta; Patrizio Sale
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.